Characterisation of antimitotic products from marine organisms that disorganise the microtubule network: Ecteinascidin 743, isohomohalichondrin-B and LL-15

British Journal of Cancer

Volumn 73, Issue 8, 1996, Pages 875-883

  Garcia Rocha M ^a   Garcia Gravalos ^b   Avila, J ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b PHARMAMAR S A   (Spain)

Author keywords

Anti tumoral compound; Cytoskeletal poison; Tubulin

Indexed keywords

ANTIMITOTIC AGENT; ANTINEOPLASTIC AGENT; COLCHICINE; GUANOSINE TRIPHOSPHATE; MICROTUBULE ASSOCIATED PROTEIN; TUBULIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MICROTUBULE; MICROTUBULE ASSEMBLY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029944528     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.176     Document Type: Article

References (26)

1. BAAS PW, PIENKOWSKI, TP CIMBALNIK KA, TOYAMA K, BAKALIS S, AHMAD FJ AND KOSIK KS. (1994). Tau confers drug-stability but not cold stability to microtubules in living cells. J. Cell Sci., 107, 135-143.
2. BAI R, PETTIT GR AND HAMEL E. (1990). Binding of dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and vinca alkaloid sites. J. Biol. Chem., 265, 17141-17149.
3. BAI R, PAULL KD, HERALD CL, MALPEIS L, PETTIT GR AND HAMEL E. (1991). Halichondrin B and homohalichondrin B, marine natural products binding to the Vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data. J. Biol. Chem., 266, 15882-15889.
4. BECK WT. (1987). The cell biology of multiple drug resistance. Biochem. Pharmacol., 36, 2879-2887.
5. DÍEZ JC, AVILA J, NIETO JM AND ANDREU JM. (1987). Reversible inhibition of microtubule and cell growth by the bicyclic colchicine analogue MTC. Cell Motil. Cytoskeleton, 7, 178-186.
6. FLAM F. (1994). Chemical prospectors scour the seas for promising drugs. Science, 266, 1324-1325.
7. GLUZMAN YY. (1981). SV40-transformed simian cells support the replication of early SW40 mutants. Cell, 23, 175-182.
8. GORDALIZA M, DEL CORRAL JM, CASTRO MA, LÓPEZ VÁZQUEZ ML, GARCÍA PA, SAN FELICIANO A AND GARCÍA-GRÁVALOS MD. (1996). Selective cytotoxic cyclolignan. Bioorg. Med. Chem. Lett., (in press).
9. HAMEL E. (1990). Interactions of tubulin with small ligands. In Microtubule Proteins, J Avila (ed.) pp. 89-191. CRC Press: Boca Raton, FL.
10. HIMES RH, BURTON PR AND GAITO JM. (1977). Dimethyl sulfoxide induced self assembly of tubulin lacking associated proteins. J. Biol. Chem., 252, 6222-6228.
11. HIRATA Y AND UEMURA D. (1986). Halichondrins: antitumour polyether macrolides from a marine sponge. Pure Appl. Chem., 58, 701-710.
12. HOEBEREK J, VAN NIJE G AND DE BRABANDER M. (1976). Interaction of oncodazol (R17934), a new antitumoral drug, with rat brain tubulin. Biochem. Biophys. Res. Commun., 69, 319-324.
13. HUANG AB, LIN CM AND HAMEL E. (1985). Maytansine inhibits nucleotide binding at the exchangable site of tubulin. Biochem. Biophys. Res. Commun., 128, 1239-1246.
14. KARR TL, WHITE HD, COUGHLIN BA AND PURICH DL. (1982). In Methods in Cell Biology, Vol 24A, Wilson L. (ed.) pp. 51-50. Academic Press: New York.
15. KLYMKOWSKY MW. (1981). Intermediate filaments in 3T3 cell, collapse after intracellular injection of a monoclonal anti-intermediate filament antibody. Nature, 291, 249-251.
16. LUDUENA RF, PRASAD V, ROACH MC AND LACEY E. (1989). The interactions of phomopsin A with bovine brain tubulin. Arch. Biochem. Biophys., 272, 32-38.
17. MOSCOW JA AND COWAN KH. (1988). Multidrug resistance. J. Natl Cancer Inst., 80, 14-20.
18. OSBORN M AND WEBER K. (1982). Immunofluorescence and immunocytochemical procedures with affinity purified antibodies: Tubulin containing structures. Methods Cell Biol., 24, 98-132.
19. ROWINSKY EK AND DONEHOWER RC. (1991). The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics. Pharmacol. Ther., 52, 35-84.
20. SCHIFF PH, FANT J AND HORWITZ SB. (1979). Promotion of tubulin assembly in vitro and by taxol. Nature, 277, 665-667.
21. SHERLINE P, BODWIN CK AND KIPNIS DM. (1974). A new colchicine binding assay for tubulin. Anal. Biochem., 62, 400-404.
22. SULLIVAN AS, PRASAD V, ROACH MC, TAKAHASHI M, IWASAKI S AND LUDUENA RF. (1990). Interaction of rhizodin with brain tubulin. Cancer Res., 50, 4277-4280.
23. TAYLOR EW. (1965). The mechanism of colchicine inhibition of mitosis. J. Cell Biol., 25, 145-160.
24. WEINGARTEN MD, LOCKWOOD H, HWO SY AND KIRSCHNER MW. (1975). A protein factor essential for microtubule assembly. Proc. Natl Acad. Sci. USA., 72, 1858-1862.
25. WHEELER GP, BOWDON BJ, WERLINE JA, ADAMSON DJ AND TEMPLE CG Jr. (1982). Inhibition of mitosis anticancer activity against experimental neoplasms by ethyl 5-amino-1,2-dihydro-3″ -(N-methyllanilino)-pyrido[3,4-b]pyrazin-7-yl-carbamate (NSC 181928). Cancer Res., 42, 791-798.
26. WILSON L. (1970). Properties of colchicine binding protein from chick embryo brain. Interactions with vinca alkaloids and podophyllotoxin. Biochemistry, 9, 4999-5006.